Annual report pursuant to Section 13 and 15(d)

Schedule of segment information (Details)

v3.22.1
Schedule of segment information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]    
Net sales $ 6,010,438 $ 4,825,956
Operating income (loss) (404,336) (1,074,104)
Interest income 70,229 92,571
Interest expense 62,392 35,295
Total asset 4,786,441 4,441,095
Property Additions 161,366 133,989
Fixed asset depreciation and amortization 51,710 27,656
Cannabis and Medical Marijuana Segment [Member]    
Segment Reporting Information [Line Items]    
Net sales 40,764 47,707
Operating income (loss) 26,849 (13,258)
Interest income
Interest expense
Total asset 900,484 1,042,553
Property Additions
Fixed asset depreciation and amortization
Facility Operations Related [Member]    
Segment Reporting Information [Line Items]    
Net sales 5,969,674 4,778,249
Operating income (loss) 95,336 (231,162)
Interest income 3
Interest expense 38,330 34,711
Total asset 2,240,047 1,874,519
Property Additions 160,102 126,396
Fixed asset depreciation and amortization 45,936 20,553
Corporate and Eliminations [Member]    
Segment Reporting Information [Line Items]    
Net sales
Operating income (loss) (526,521) (829,684)
Interest income 70,226 92,571
Interest expense 24,062 584
Total asset 1,645,910 1,524,023
Property Additions 1,264 7,593
Fixed asset depreciation and amortization $ 5,744 $ 7,103